Markets:

Overview

News

Currencies

International

Treasuries

Blue Bird Corporation - Common Stock (NQ:BLBD)

49.57 -0.49 (-0.98%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Blue Bird Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Looking for growth without the hefty price tag? Consider NASDAQ:BLBD. ↗

April 16, 2024

While growth is established for BLUE BIRD CORP (NASDAQ:BLBD), the stock's valuation remains reasonable.

Via Chartmill

Ahead of the Curve: 7 Stocks to Buy Before They Go Mainstream ↗

April 10, 2024

Discover seven overlooked stocks to buy poised for 10X returns across diverse industries. Unlock their growth potential now.

Via InvestorPlace

Despite its impressive fundamentals, NASDAQ:BLBD remains undervalued. ↗

April 08, 2024

Investors should take notice ofBLUE BIRD CORP (NASDAQ:BLBD)—it offers a great deal for the fundamentals it presents.

Via Chartmill

Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Wednesday Morning

April 03, 2024

Via Investor Brand Network

Topics Energy

Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning

March 28, 2024

Via Investor Brand Network

Topics Energy

Is NASDAQ:BLBD suited for growth investing? ↗

March 26, 2024

High growth, ROE and beating expectations for NASDAQ:BLBD: growth investors may appreciate this.

Via Chartmill

NASDAQ:BLBD, a growth stock which is not overvalued. ↗

March 26, 2024

BLUE BIRD CORP (NASDAQ:BLBD), a growth stock which is not overvalued.

Via Chartmill

Is NASDAQ:BLBD a Fit for Growth Investing Strategies? ↗

March 05, 2024

Why BLUE BIRD CORP (NASDAQ:BLBD) qualifies as a high growth stock.

Via Chartmill

NASDAQ:BLBD is not too expensive for the growth it is showing. ↗

March 05, 2024

BLUE BIRD CORP (NASDAQ:BLBD) stands out as a growth opportunity that won't break the bank.

Via Chartmill

7 EV Stocks That Could Be Multibaggers in the Making: March Edition ↗

March 26, 2024

Discover EV stocks poised for explosive growth, tapping into cutting-edge technology and market dominance.

Via InvestorPlace

3 Promising Small-Cap Stocks Packing a Powerful Punch ↗

March 23, 2024

Here're three under-the-radar small-cap stocks with robust growth potential that could deliver outsized returns for risk-tolerant investors.

Via InvestorPlace

Beat Wall Street: 3 Stocks Flying Under the Radar ↗

March 05, 2024

The market is full of many companies that most people haven’t even heard of. Add these stocks to your portfolio that fly under the radar.

Via InvestorPlace

Blue Bird Corp. (NASDAQ: BLBD) Sets New 52-Week High in Friday Session

March 01, 2024

Via Investor Brand Network

Topics Energy

7 Must-Buy Stocks for a Diversified High-Growth Portfolio ↗

March 01, 2024

Explore how these high-growth portfolio stocks can drive substantial returns in IT, communication, industrials, and financials.

Via InvestorPlace

What 4 Analyst Ratings Have To Say About Blue Bird ↗

February 29, 2024

Via Benzinga

Should you consider NASDAQ:BLBD for growth investing? ↗

February 13, 2024

BLUE BIRD CORP (NASDAQ:BLBD) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

NASDAQ:BLBD stands out as a growth opportunity that won't break the bank. ↗

February 13, 2024

NASDAQ:BLBD is not too expensive for the growth it is showing.

Via Chartmill

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

February 27, 2024

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...

Via Newsfile

Is CRISPR Therapeutics the NVIDIA of gene editing?

February 26, 2024

CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approv

Via MarketBeat

Topics Artificial Intelligence

Wall Street Favorites: 3 EV Stocks With Strong Buy Ratings for February 2024 ↗

February 23, 2024

Though the certainty of the electric vehicle industry may be waning, these three EV stocks offer strong potential nonetheless.

Via InvestorPlace

Topics Electric Vehicles

Blue Bird: Q1 Earnings Insights ↗

February 07, 2024

Via Benzinga

Earnings Scheduled For February 7, 2024 ↗

February 07, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.

Via Benzinga

3 Goliath Growth Stocks Poised for Takeoff in February ↗

February 19, 2024

These three top-tier growth stocks to buy offer investors incredible potential returns and are perfect for long-term investing.

Via InvestorPlace

Blue Bird Announces Launch of Secondary Public Offering

February 15, 2024

From Blue Bird Corporation

Via Business Wire

Gene therapy: Why does it cost millions for a single treatment?

February 15, 2024

Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology.

Via MarketBeat

Win-Win Situation? Nuvve's (NASDAQ: NVVE) Technology Can Potentially Turn Your Electric Vehicle Into A Revenue Stream That Helps Support The Power Grid ↗

February 14, 2024

Electric vehicles seem poised to take over the roads, reducing global emissions and helping the world achieve a greener future.

Via Benzinga

Topics Electric Vehicles Emissions

Blue Bird Corp. (NASDAQ: BLBD) Records 52-Week High Thursday Morning

February 08, 2024

Via Investor Brand Network

Topics Energy

12 Industrials Stocks Moving In Thursday's Pre-Market Session ↗

February 08, 2024

Via Benzinga

12 Industrials Stocks Moving In Wednesday's After-Market Session ↗

February 07, 2024

Via Benzinga

Blue Bird Reports Fiscal 2024 First Quarter Record Results; Raises 2024 Guidance

February 07, 2024

From Blue Bird Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Blue Bird Corporation - Common Stock (NQ:BLBD)

All News about Blue Bird Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today